No Data
Express News | Abbvie : BMO Raises Target Price to $220 From $214
AbbVie Initiated With a Market Perform at Bernstein
Bernstein starts to focus on US pharmaceutical stocks, giving Eli Lilly and Co (LLY.US) and others a "outperforming the large cap" rating.
Bernstein starts covering Eli Lilly and Co (LLY.US), Gilead Sciences (GILD.US), and Amgen (AMGN.US), all with an "outperform" rating.
Lilly, Gilead, Amgen Started at Outperform by Bernstein
AbbVie Hits 9-week Low
Allergan Aesthetics to Present New Data at 2024 American Society for Dermatologic Surgery (ASDS) to Showcase Depth Across Facial Aesthetics and Insight Into Patient Perception
loading...